Research has identified key biomarkers related to inflammation, such as the inflammasome, GDF-15, and immune cells impacting ox-LDL serum levels, particularly relevant in younger CAD patients for prognostic insights. This evidence concerns the gene GDF15 and coronary artery disorder.